GCP-enheden ved Aalborg og Aarhus Universitetshospitaler
GCP-enheden ved Aalborg og Aarhus Universitetshospitaler is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 5 of 5 trials · Latest update first
Short-term combined acalabrutinib and venetoclax treatment of newly diagnosed patients with CLL at high risk of infection and/or early treatment, who do not fulfil IWCLL treatment criteria for treatment. A randomized study with extensive immune phenotyping.
Sponsor Rigshospitalet
- Start (EU)
- Latest update
- Estimated end
- Not reported
Isa-RVD Study: Phase II, Multi-centre, Single-Arm, Open-Label Study to evaluate the efficacy and safety of the combination regimen Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
Sponsor Cancer Trials Ireland
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Randomised controlled trial to compare efficacy and tolerability of Plenvu® and Picoprep® as cleansing agents before colonoscopy
Sponsor Aalborg University Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Teicoplanin as Infection Prophylaxis in Pediatric Acute Myeloid Leukemia (Pro-Teico study) An open-label, randomized clinical trial on teicoplanin infection prophylaxis in pediatric patients with acute myeloid leukemia
Sponsor Prinses Maxima Centrum voor Kinderoncologie B.V.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL)
Sponsor Aalborg University Hospital
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for GCP-enheden ved Aalborg og Aarhus Universitetshospitaler?
The 2026-10-09 snapshot links GCP-enheden ved Aalborg og Aarhus Universitetshospitaler to 5 distinct CTIS trials. Recorded services include Clinical monitoring. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for GCP-enheden ved Aalborg og Aarhus Universitetshospitaler?
The most frequently recorded therapeutic areas are Haematological Malignancies. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to GCP-enheden ved Aalborg og Aarhus Universitetshospitaler conducted?
The linked trials record locations in 7 countries, including Denmark, Netherlands, Sweden, Belgium, Spain. These are trial locations, not confirmed office locations or countries where GCP-enheden ved Aalborg og Aarhus Universitetshospitaler delivered services.
What can this page tell me about GCP-enheden ved Aalborg og Aarhus Universitetshospitaler's trial experience?
Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under GCP-enheden ved Aalborg og Aarhus Universitetshospitaler. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- GCP-enheden ved Aalborg og Aarhus Universitetshospitaler